leisure time -WSS

leisure time

author：hotspot 2025-09-03 03:45:14 - browse：7

Scanned cerebellum of a mouse brain, affected by Niemann-Pick Type C, shown in pink and teal — biotech coverage from STAT — The cerebellum of a mouse brain affected by Niemann-Pick Type C. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health

About a decade ago, Tatiana Bremova-Ertl’s graduate adviser was studying an obscure, 1950s-era French vertigo drug, probing its effects on people with balance disorders, when she thought of another, very sick group of patients.

A graduate student and medical resident at the German Center for Vertigo and Balance Disorders, in Munich, Bremova-Ertl often saw patients with Niemann-Pick Type C, a rare, genetic disease that slowly kills neurons.

NPC has a range of manifestations. When symptoms appear in early childhood, it is often fatal before adulthood. When it manifests later, it can be milder. But it’s always degenerative and leads to a cluster of challenges: cognitive decline, difficulty with speech and swallowing, enlarged liver, low muscle tone, and, notably, difficulty with balance and muscle control. Researchers and a fervent group of parents were working to develop medicines, but little had yet worked.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

WSS

ReNAgade cuts staff seven months after raising $300 million

Organ aging and disease risk measured by new blood test

Hottest summer in 2,000 years puts focus on extreme heat, health

With clinical trial data readouts, here's how to spot spin

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Organ aging and disease risk measured by new blood test

leisure time

leisure time

explore

Malaria cases in Florida and Texas: Here’s what you need to know

With clinical trial data readouts, here's how to spot spin

Sports medicine is finally prioritizing gender equality

Free medical tuition alone isn't enough to close gaps in primary care

Psychedelics group wrestles with new pharma identity

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Alkermes shareholders re

Obesity drug from Roche shows promise in early study

Continuity nursing helped my family in our darkest PICU moments

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

focus

CDC director unscathed in first congressional testimony

ReNAgade cuts staff seven months after raising $300 million

What a koala virus tells us about the human genome

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Free medical tuition alone isn't enough to close gaps in primary care

hotspot

explore

focus

hotspot